INHERITED AND ACQUIRED THROMBOTIC RISK FACTORS IN WOMEN WITH A HISTORY OF OBSTETRIC PATHOLOGY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective: to study the detection rate of genetic polymorphisms associated with thrombophilia, as well as the structure of thrombotic risk factors and the pattern of chronic somatic diseases in women with a history of obstetric complications. Subjects and methods. One hundred and five women whose mean age was 30.5±5.1 years were examined. The inclusion criteria were a history of recurrent miscarriage; more than 1 loss at 10 weeks or more gestational age; early fetal death; severe preeclampsia; placental insufficiency; premature detachment of a normally situated placenta; two unsuccessful IVF attempts or more. The exclusion criteria were fetal chromosomal abnormalities with reproductive loss; a patient’s refusal to participate in the study. The investigators performed clinical examination, molecular genetic testing for Factor V Leiden (FVL), F II G20210A, C677T MTHFR, Fgb 455 G>A, Leu33Pro GP IIb/IIIa, PAI-1 675 5G>4G and determined lupus anticoagulant, IgM and IgG anticardiolipin antibodies, β2-glycoprotein 1 antibodies, and made quantitative assay of antithrombin III activity. Results. Inherited thrombophilias were found in 102 (97%) cases; of them 85% women had mixed thrombophilias. Antiphospholipid antibodies were detected in 23% of patients, their association with polymorphisms to thrombotic diseases being observed in 21% of cases. The rate of the detected antiphospholipid syndrome was 3.8%. Other risk factors were encountered with a high frequency; these were chronic endometritis (51%), overweight and obesity (40%), and use of combination oral contraceptives (44%). More than one third of the women had a combination of a few risk factors and chronic extragenital diseases.

Full Text

Restricted Access

About the authors

V. F DOLGUSHINA

Chelyabinsk State Medical Academy, Russian Agency for Health Care

Email: vereinank@chelcom.ru

N. K VEREINA

Chelyabinsk State Medical Academy, Russian Agency for Health Care

References

  1. Айламазян Э.К., Зайнулина М.С. Наследственная тромбофилия: дифференцированный подход к оценке риска акушерских осложнений // Акуш. и гин. — 2010. — № 3. — С. 3—9.
  2. Васильев С. А. Роль наследственности в развитии тромбозов // Тромбоз, гемостаз и реология. — 2007. — № 3. — С. 3—14.
  3. Макацария А.Д., Бицадзе В.О., Акиньшина А.В. Тромбозы и тромбоэмболии в акушерско-гинекологической клинике. Молекулярно-генетические механизмы и стратегия профилактики тромбоэмболических осложнений: Руководство для врачей. — М.: ООО «МИА», 2007.
  4. Профилактика повторных осложнений беременности в условиях тромбофилии (синдром потери плода, гестозы, преждевременная отслойка нормально расположенной плаценты, тромбозы и тромбоэмболии): руководство для врачей / Под ред. А.Д. Макацария. — М.: Триада-Х, 2008.
  5. Сидельникова В.М. Невынашивание беременности — современный взгляд на проблему // Акуш. и гин. — 2007. — № 5. — С. 24—27.
  6. Brenner B. Thrombophilia in pregnancy and its role in abortion // Womens Health. — 2005. — Vol. 1, № 1. — P. 35—38.
  7. Kujovich J.L. Thrombophilia and pregnancy complications // Am. J. Obstet. Gynecol. — 2004. — Vol. 191. — P. 412— 424.
  8. Rosendaal F.R., Doggen C. J., Zivelin M. et al. Geografic distribution of the 20210 G to A prothrombin variant // J. Thromb. Haemost. — 1998. — Vol. 79. — P. 706—708.
  9. Stein P.D., Hull R.D., Kayali F. et al. Venous thromboembolism inpregnancy: 21-yeartrends // Am. J. Med. —2004. —Vol. 117. — P. 121—125.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies